logo-loader
NASDAQ:ACAD

ACADIA Pharmaceuticals Inc.

Receive alerts
Market:
NASDAQ
Market Cap:
$4.22 billion
Price
$29.21
Change
-2.08%
52 weeks high
30.38
52 weeks low
13.18

In brief

ACADIA Pharmaceuticals (NASDAQ: ACAD) is a biopharmaceutical company focused on innovative small molecule drugs that address unmet medical needs in neurological and related central nervous system disorders. We have a pipeline of product candidates led by pimavanserin, which is in Phase III development as a potential first-in-class treatment for Parkinson's disease psychosis.